Device for the transcutaneous electrical stimulation of the trigeminal nerve
A device for the transcutaneous electrical stimulation of the trigeminal nerve is provided. The device has an elongated symmetrical support with at least one electrode pair, and the support can be applied on a person's forehead in the supraorbital region to cover the afferent paths of the supratrochlear and supraorbital nerves of the ophthalmic branch of the trigeminal nerve. Each electrode pair contacts a self-adhesive conductive gel that at least partially covers one surface of the support for attaching the support to the forehead to be applied to two lateral zones with the exception of an insulating central zone. Each lateral zone has one electrode of the electrode pair, an electric circuit for supplying to the electrode pair electric pulses that have a predefined intensity, and a measurement means for measuring the intensity of the supplied pulses that is connected to the electric circuit.
1. A device for transcutaneous electrical stimulation of a trigeminal nerve, comprising:
an elongated symmetrical support having at least one electrode pair and at least one microcontroller unit, the support having two lateral zones and an insulating central zone, each lateral zone having one electrode of the electrode pair and at least one electric circuit configured to supply to the electrode pair electric pulses having a predefined intensity, the at least one electric circuit being connected to the at least one microcontroller unit, the microcontroller unit being configured to measure an intensity of the supplied pulses and to steer the pulses, the support configured to be applied on a forehead of a person's face in a supraorbital region such that afferent paths of supratrochlear and supraorbital nerves of an ophthalmic branch of the trigeminal nerve are covered; and
an auditory signal control mechanism configured to control an auditory signal, the auditory signal control mechanism being connected to the at least one microcontroller unit and being configured to create the auditory signal when the measured intensity is different from the predefined intensity;
wherein each electrode pair is in contact with a self-adhesive conductive gel, the conductive gel at least partially covers one surface of the support for attaching the support to the forehead and is applied to the two lateral zones and is not applied to the insulating central zone.
2. The device according to claim 1 , wherein the predefined intensity of the pulses is from 1 to 35 mA.
3. The device according to claim 1 , further comprising at least one monitoring means configured to record a plurality of parameters during each use of the device, wherein said monitoring means is connected to the electric circuit and has at least one of a sensor and a storage means configured to store the recorded plurality of parameters.
4. The device according to claim 3 , wherein the plurality of parameters are selected from the group consisting of: a number of treatment sessions performed by the device, a total time of treatment sessions, a maximum pulse intensity used throughout all sessions, a frequently used pulse intensity throughout all sessions, a total charge transferred to the person throughout all sessions, and any combination thereof.
5. The device according to claim 1 , further comprising at least one biofeedback means for recording a physical response of the person to the supplied pulses, wherein the biofeedback means is connected to the electrode of the device and has at least one conversion means for converting the recorded physical responses into a biofeedback signal that is configured to be perceived by the person.
6. The device according to claim 5 , wherein the biofeedback signal is at least one of a visual and an auditory signal.
7. The device according to claim 1 , wherein the electric circuit has a programmable signal generator configured to generate electrical pulses of a duration of between 150 and 450 microseconds with a maximum increase in intensity of 0 to 20 mA at a rate of less than or equal to 40 microamperes per second and with a step up in intensity not exceeding 50 microamperes.
8. The device according to claim 1 , wherein the electric circuit is integrated into an apparatus, and the apparatus is mechanically connectable to the elongated symmetrical support.
9. The device according to claim 1 , wherein the electric circuit is integrated into an apparatus, and the apparatus is magnetically connectable to the elongated symmetrical support.
10. The device according to claim 1 , wherein the device is configured for use in electrotherapeutic treatment of neurological disorders selected from the group consisting of migraine, tension, headaches, cluster headaches, hemicrania continua, Semi unilateral neuralgaform non conjunctival tearing (SUCNT), chronic paroxystic hemicranias, trigeminal neuralgia, facial nerve disturbances, fibromyalgia, chronic pain, depression, cyclothymia, post-traumatic stress syndrome, post-concussion syndrome, coma, anxiety, tremor, aphasia, obsessive compulsive disorder, insomnia, sleep disorders, sleep apnea syndrome, hypersomnia, epilepsy, drop attacks, attention deficit hyperactivity disorder, Parkinson's disease, Alzeihmer's disease, multiple sclerosis, stroke, and Cerebellar syndrome.
11. A kit comprising a device as described in claim 1 and a leaflet with instructions to a user.
12. A device for transcutaneous electrical stimulation of a trigeminal nerve of a person, comprising:
an elongated symmetrical support having at least one electrode pair and at least one microcontroller unit, the at least one electrode pair configured to supply electric pulses having a predefined intensity, the microcontroller unit being configured to measure an intensity of the supplied pulses and to steer the pulses, the support having two lateral zones and an insulating central zone, each lateral zone having one electrode of the electrode pair, the support being configured to be applied on a forehead of the person in a supraorbital region such that afferent paths of supratrochlear and supraorbital nerves of an ophthalmic branch of the trigeminal nerve are covered;
an auditory signal control mechanism connected to the at least one microcontroller, the auditory signal control mechanism configured to create an auditory signal when the measured intensity is different from the predefined intensity; and
self-adhesive conductive gel at least partially covering the two lateral zones.
13. The device according to claim 12 , wherein the predefined intensity of the pulses is from 1 to 35 mA.
14. The device according to claim 12 , further comprising at least one monitor configured to record a plurality of parameters during each use of the device, the monitor having at least one of a sensor and a storage means configured to store the recorded plurality of parameters.
15. The device according to claim 14 , wherein the plurality of parameters are selected from the group consisting of: a number of treatment sessions performed by the device, a total time of treatment sessions, a maximum pulse intensity used throughout all sessions, a frequently used pulse intensity throughout all sessions, a total charge transferred to the person throughout all sessions, and any combination thereof.
16. The device according to claim 12 , further comprising at least one biofeedback mechanism for recording a physical response of the person to the supplied pulses, the biofeedback mechanism being connected to the electrode pair and having at least one conversion mechanism configured to convert the recorded physical responses into a biofeedback signal that is configured to be perceived by the person.
17. The device according to claim 16 , wherein the biofeedback signal is at least one of a visual and an auditory signal.
18. The device according to claim 12 , further comprising a programmable signal generator configured to generate electrical pulses of a duration of between 150 and 450 microseconds with a maximum increase in intensity of 0 to 20 mA at a rate of less than or equal to 40 microamperes per second and with a step up in intensity not exceeding 50 microamperes.
19. A kit comprising the device of claim 12 and a leaflet with instructions to a user.